Gindele Réka

1.

Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, (article identifier: 2893), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2.

Kerényi, A., Schlammadinger, Á., Szegedi, I., Kiss, C., Marton, I., Bagoly, Z., Gindele, R., Boda, Z., Kappelmayer, J., Bereczky, Z.: von Willebrand betegség komplex laboratóriumi diagnosztikája egyetemi központban.
Hematol. Trasnzfuziol. 57 (3), 182, 2024.

DEA

3.

Bereczky, Z., Gindele, R., Fiatal, S., Speker, M., Miklós, T., Balogh, L., Mezei, Z. A., Szabó, Z., Ádány, R.: Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.
Front. Cardiovasc. Med. 7, 1-15, (article identifier: 617711), 2021.

doi DEA

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

4.

Major, T., Bereczky, Z., Gindele, R., Balogh, G., Rácz, B., Bora, L., Kézsmárki, Z., Brúgós, B., Pfliegler, G.: Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary.
J Clin Med. 10 (17), 1-17, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

5.

Major, T., Gindele, R., Balogh, G., Bárdossy, P., Bereczky, Z.: Founder Effects in Hereditary Hemorrhagic Telangiectasia.
J Clin Med. 10 (8), 1-20, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

6.

Morena-Barrio, M. E., Gindele, R., Bravo-Pérez, C., Ilonczai, P., Zuazu, I., Speker, M., Oláh, Z., Rodríguez-Sevilla, J. J., Entrena, L., Infante, M. S., Morena-Barrio, B., García, J. M., Schlammadinger, Á., Cifuentes-Riquelme, R., Mora, C. A., Miñano, A., Padilla, J., Vicente, V., Corral, J., Bereczky, Z.: High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: description of a new syndrome.
Am. J. Hematol. 96 (11), 1363-1373, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

7.

Gindele, R., Pénzes-Daku, K., Balogh, G., Kállai, J., Kissné Bogáti, R., Bécsi, B., Erdődi, F., Katona, É., Bereczky, Z.: Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.
Biomolecules. 11 (4), 1-18, (article identifier: 544), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Molecular Biology

8.

Gindele, R., Kerényi, A., Kállai, J., Pfliegler, G., Schlammadinger, Á., Szegedi, I., Major, T., Szabó, Z., Bagoly, Z., Kiss, C., Kappelmayer, J., Bereczky, Z.: Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.
Life (Basel). 11 (3), 1-23, (article identifier: 202), 2021.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Ecology, Evolution, Behavior and Systematics

Q2 Paleontology

Q3 Space and Planetary Science

9.

Reményi, G., Bereczky, Z., Gindele, R., Ujfalusi, A., Illés, Á., Udvardy, M.: rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics.
Pathol. Oncol. Res. 27, 1-6, 2021.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

10.

Major, T., Csobay-Novák, C., Gindele, R., Szabó, Z., Bora, L., Jóni, N., Rácz, T., Karosi, T., Bereczky, Z.: Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia.
J. Int. Med. Res. 48 (2), 1-7, 2020.

doi DEA

Journal metrics:

Q3 Biochemistry

Q3 Biochemistry (medical)

Q4 Cell Biology

Q3 Medicine (miscellaneous)

11.

Major, T., Gindele, R., Szabó, Z., Kis, Z., Bora, L., Jóni, N., Bárdossy, P., Rácz, T., Bereczky, Z.: The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia.
Pathol. Oncol. Res. 26 (4), 2783-2788, 2020.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

12.

Major, T., Gindele, R., Szabó, Z., Jóni, N., Kis, Z., Bora, L., Bárdossy, P., Rácz, T., Karosi, T., Bereczky, Z.: A herediter haemorrhagiás teleangiectasia (Osler-Weber-Rendu-kór) genetikai diagnosztikája.
Orv. hetil. 160 (18), 710-719, 2019.

doi DEA WoS Scopus

Journal metrics:

Q3 Medicine (miscellaneous)

13.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z. A., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.

doi DEA

14.

Balogh, L., Katona, É., Mezei, Z. A., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

doi DEA

Journal metrics:

Q3 Cell Biology

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

Q3 Molecular Biology

15.

Miklós, T., Balla, G., Balogh, L., Boda, Z., Szabó, Z., Molnár, É., Gindele, R., Katona, É., Bereczky, Z.: Effects of Serpinc1, Proc, Pros1 and Epcr Polymorphisms on the Plasma Levels of Natural Anticoagulants in Healthy Individuals and on the Risk of Venous Thromboembolism and Myocardial Infarction.
Proceedings. 2 (9), 78, 2018.

doi DEA

16.

Miklós, T., Balla, G., Balogh, L., Boda, Z., Szabó, Z., Molnár, É., Gindele, R., Katona, É., Bereczky, Z.: Effects of SERPINC1, PROC, PROS1 and EPCR Polymorphisms on the Risk of Venous Thromboembolism and Myocardial Infarction in Young Individuals.
Res Pract Thromb Haemost. 2, 178, 2018.

doi DEA

17.

Gindele, R., Colombo, R., Szabó, Z., Speker, M., Mezei, Z. A., Balogh, L., Katona, É., Bagoly, Z., Fiatal, S., Bereczky, Z.: Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.

doi DEA

18.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z. A., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2, 324-324, 2018.

doi DEA

19.

Selmeczi, A., Gindele, R., Ilonczai, P., Fekete, A., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Kovács, K. B., Bárdos, H., Ádány, R., Muszbek, L., Bereczky, Z., Boda, Z., Oláh, Z.: Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.
Thromb. Res. 158, 1-7, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

20.

Gindele, R., Selmeczi, A., Oláh, Z., Ilonczai, P., Pfliegler, G., Marján, E., Nemes, L., Nagy, Á., Losonczy, H., Mitic, G., Kovac, M., Balogh, G., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z., Muszbek, L., Bereczky, Z.: Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center.
Thromb. Res. 160, 119-128, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

21.

Bereczky, Z., Gindele, R., Speker, M., Kállai, J.: Deficiencies of the natural anticoagulants: novel clinical laboratory aspects of thrombophilia testing.
EJIFCC. 27 (2), 130-146, 2016.

DEA

22.

Bereczky, Z., Speker, M., Gindele, R., Szabó, Z., Oláh, Z., Pfliegler, G., Kerényi, A., Boda, Z.: Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory.
J. Throm. Haemost. 14 (Suppl.), 98, 2016.

doi DEA WoS

23.

Major, T., Gindele, R., Szabó, Z., Alef, T., Thiele, B., Bora, L., Kis, Z., Bárdossy, P., Rácz, T., Havacs, I., Bereczky, Z.: Evidence for the founder effect of a novel ACVRL1 splice-site mutation in Hungarian hereditary hemorrhagic telangiectasia families.
Clin. Genet. 90 (5), 466-467, 2016.

doi DEA

Journal metrics:

Q2 Genetics

Q2 Genetics (clinical)

24.

Gindele, R., Oláh, Z., Ilonczai, P., Speker, M., Udvari, Á., Selmeczi, A., Pfliegler, G., Marján, E., Kovács, B., Boda, Z., Muszbek, L., Bereczky, Z.: Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
J. Thromb. Haemost. 14 (4), 704-715, 2016.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

D1 Medicine (miscellaneous)

25.